The GLP-1 liraglutide showed potential benefit in reducing stroke recurrence and improving functional outcomes after minor ...

b.i.d.: Twice daily; LEAD: Liraglutide Effect and Action Diabetes ... for the 'incretin effect', a phenomenon in which where more insulin is secreted in response to glucose ingested during ...

Soliqua 100/33 vs. Xultophy 100/3.6 To see a detailed comparison of Soliqua 100/33 with the combination drug insulin degludec and liraglutide (Xultophy 100/3.6), refer to the “Soliqua 100/33 vs.

A thorough examination of modern drugs that target particular receptors and metabolic pathways for glucose and fat metabolism is presented. Recent research has revealed innovative targets and ...

Novo Nordisk’s GLP-1 agonist Victoza has become the first non-insulin drug to be approved in the US as a treatment for type 2 diabetes in children for almost two decades.

Yes, weightloss drugs can help you lose weight – but they can also boost your health in unexpected ways. Good Housekeeping’s ...